HEADER OXIDOREDUCTASE 20-OCT-14 4D34 TITLE STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE HEME TITLE 2 DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL)PYRIMIDIN-4- TITLE 3 YL)-N-(3-FLUOROPHENETHYL)ETHAN-1-AMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NITRIC OXIDE SYNTHASE, ENDOTHELIAL; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: HEME DOMAIN, UNP RESIDUES 40-482; COMPND 5 SYNONYM: CONSTITUTIVE NOS, CNOS, EC-NOS, ENDOTHELIAL NOS, ENOS, NOS COMPND 6 TYPE III, NOSIII, ENDOTHELIAL NITRIC OXIDE SYNTHASE; COMPND 7 EC: 1.14.13.39; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 3 ORGANISM_COMMON: CATTLE; SOURCE 4 ORGANISM_TAXID: 9913; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PCWORI KEYWDS OXIDOREDUCTASE, NITRIC OXIDE SYNTHASE, INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR G.CHREIFI,H.LI,T.L.POULOS REVDAT 2 04-MAR-15 4D34 1 JRNL REVDAT 1 24-DEC-14 4D34 0 JRNL AUTH P.MUKHERJEE,H.LI,I.SEVRIOUKOVA,G.CHREIFI,P.MARTASEK, JRNL AUTH 2 L.J.ROMAN,T.L.POULOS,R.B.SILVERMAN JRNL TITL NOVEL 2,4-DISUBSTITUTED PYRIMIDINES AS POTENT, SELECTIVE, JRNL TITL 2 AND CELL-PERMEABLE INHIBITORS OF NEURONAL NITRIC OXIDE JRNL TITL 3 SYNTHASE. JRNL REF J.MED.CHEM. V. 58 1067 2015 JRNL REFN ISSN 0022-2623 JRNL PMID 25489882 JRNL DOI 10.1021/JM501719E REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU, REMARK 3 STEINER,NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 98.77 REMARK 3 NUMBER OF REFLECTIONS : 44238 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.17851 REMARK 3 R VALUE (WORKING SET) : 0.17580 REMARK 3 FREE R VALUE : 0.23061 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 2320 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.250 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.308 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2959 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 90.85 REMARK 3 BIN R VALUE (WORKING SET) : 0.450 REMARK 3 BIN FREE R VALUE SET COUNT : 139 REMARK 3 BIN FREE R VALUE : 0.510 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6440 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 205 REMARK 3 SOLVENT ATOMS : 173 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.811 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.82 REMARK 3 B22 (A**2) : -1.43 REMARK 3 B33 (A**2) : -1.39 REMARK 3 B12 (A**2) : 0.00 REMARK 3 B13 (A**2) : 0.00 REMARK 3 B23 (A**2) : 0.00 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.256 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.208 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.192 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 16.325 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.971 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6838 ; 0.014 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 6319 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 9334 ; 1.697 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): 14491 ; 0.866 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 808 ; 6.689 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 321 ;34.180 ;23.396 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1048 ;16.814 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 54 ;18.269 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 979 ; 0.091 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 7786 ; 0.008 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1676 ; 0.005 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3238 ; 2.584 ; 3.806 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 3237 ; 2.583 ; 3.805 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4041 ; 3.864 ; 5.697 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3600 ; 3.236 ; 4.211 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 67 A 482 REMARK 3 ORIGIN FOR THE GROUP (A): 11.0953 10.4024 31.8422 REMARK 3 T TENSOR REMARK 3 T11: 0.0778 T22: 0.0113 REMARK 3 T33: 0.1670 T12: -0.0235 REMARK 3 T13: 0.0032 T23: -0.0034 REMARK 3 L TENSOR REMARK 3 L11: 0.7472 L22: 1.1138 REMARK 3 L33: 1.3127 L12: -0.1687 REMARK 3 L13: -0.3343 L23: 0.2738 REMARK 3 S TENSOR REMARK 3 S11: 0.0016 S12: 0.0038 S13: 0.0015 REMARK 3 S21: -0.1678 S22: 0.0451 S23: -0.1552 REMARK 3 S31: -0.0535 S32: 0.0813 S33: -0.0467 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 69 B 482 REMARK 3 ORIGIN FOR THE GROUP (A): 2.6809 6.0440 67.6478 REMARK 3 T TENSOR REMARK 3 T11: 0.0554 T22: 0.0284 REMARK 3 T33: 0.1776 T12: -0.0141 REMARK 3 T13: -0.0035 T23: -0.0048 REMARK 3 L TENSOR REMARK 3 L11: 0.4928 L22: 1.1010 REMARK 3 L33: 2.1313 L12: -0.2036 REMARK 3 L13: 0.2405 L23: -0.7978 REMARK 3 S TENSOR REMARK 3 S11: 0.0428 S12: -0.1144 S13: -0.0336 REMARK 3 S21: 0.1025 S22: 0.0559 S23: 0.0446 REMARK 3 S31: 0.0126 S32: -0.0765 S33: -0.0986 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. U VALUES WITH TLS ADDED. REMARK 3 RESIDUES 110 TO 120 IN BOTH CHAIN A AND CHAIN B ARE REMARK 3 DISORDERED. REMARK 4 REMARK 4 4D34 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-OCT-14. REMARK 100 THE PDBE ID CODE IS EBI-62014. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-DEC-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL (PILATUS) REMARK 200 DETECTOR MANUFACTURER : DECTRIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 47016 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.25 REMARK 200 RESOLUTION RANGE LOW (A) : 50.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 5.8 REMARK 200 R MERGE (I) : 0.09 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.00 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.37 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.5 REMARK 200 R MERGE FOR SHELL (I) : 1.50 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 0.80 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: RMERGE 2.327 RPIM 1.058 CC ONE HALF 0.438 REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.7 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.5 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20-22% PEG3350, 0.1 M REMARK 280 CACODYLATE, 150-200 MM MG ACETATE, 5 MM TCEP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.07950 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.31900 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 53.31600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.31900 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.07950 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 53.31600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 12220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -126.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 40 REMARK 465 ALA A 41 REMARK 465 PRO A 42 REMARK 465 ALA A 43 REMARK 465 PRO A 44 REMARK 465 ALA A 45 REMARK 465 THR A 46 REMARK 465 PRO A 47 REMARK 465 HIS A 48 REMARK 465 ALA A 49 REMARK 465 PRO A 50 REMARK 465 ASP A 51 REMARK 465 HIS A 52 REMARK 465 SER A 53 REMARK 465 PRO A 54 REMARK 465 ALA A 55 REMARK 465 PRO A 56 REMARK 465 ASN A 57 REMARK 465 SER A 58 REMARK 465 PRO A 59 REMARK 465 THR A 60 REMARK 465 LEU A 61 REMARK 465 THR A 62 REMARK 465 ARG A 63 REMARK 465 PRO A 64 REMARK 465 PRO A 65 REMARK 465 GLU A 66 REMARK 465 LYS A 110 REMARK 465 LEU A 111 REMARK 465 GLN A 112 REMARK 465 THR A 113 REMARK 465 ARG A 114 REMARK 465 PRO A 115 REMARK 465 SER A 116 REMARK 465 PRO A 117 REMARK 465 GLY A 118 REMARK 465 PRO A 119 REMARK 465 PRO A 120 REMARK 465 ARG B 40 REMARK 465 ALA B 41 REMARK 465 PRO B 42 REMARK 465 ALA B 43 REMARK 465 PRO B 44 REMARK 465 ALA B 45 REMARK 465 THR B 46 REMARK 465 PRO B 47 REMARK 465 HIS B 48 REMARK 465 ALA B 49 REMARK 465 PRO B 50 REMARK 465 ASP B 51 REMARK 465 HIS B 52 REMARK 465 SER B 53 REMARK 465 PRO B 54 REMARK 465 ALA B 55 REMARK 465 PRO B 56 REMARK 465 ASN B 57 REMARK 465 SER B 58 REMARK 465 PRO B 59 REMARK 465 THR B 60 REMARK 465 LEU B 61 REMARK 465 THR B 62 REMARK 465 ARG B 63 REMARK 465 PRO B 64 REMARK 465 PRO B 65 REMARK 465 GLU B 66 REMARK 465 GLY B 67 REMARK 465 PRO B 68 REMARK 465 GLN B 112 REMARK 465 THR B 113 REMARK 465 ARG B 114 REMARK 465 PRO B 115 REMARK 465 SER B 116 REMARK 465 PRO B 117 REMARK 465 GLY B 118 REMARK 465 PRO B 119 REMARK 465 PRO B 120 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 363 CG A GLU A 363 CD A 0.115 REMARK 500 GLU B 363 CG GLU B 363 CD 0.144 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 252 NE - CZ - NH2 ANGL. DEV. = -3.6 DEGREES REMARK 500 GLU A 363 OE1 - CD - OE2 ANGL. DEV. = -9.0 DEGREES REMARK 500 GLU B 363 OE1 - CD - OE2 ANGL. DEV. = -8.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 69 44.86 -78.44 REMARK 500 PRO A 108 49.38 -107.18 REMARK 500 ALA A 122 -74.40 55.18 REMARK 500 LYS A 194 69.76 -111.48 REMARK 500 SER A 262 -169.91 -71.99 REMARK 500 ASN A 285 33.23 -150.60 REMARK 500 PHE A 288 39.69 -148.03 REMARK 500 ALA A 353 67.93 -163.15 REMARK 500 ARG A 374 -128.57 -112.89 REMARK 500 ASP A 386 32.61 74.47 REMARK 500 ARG A 440 -4.59 -140.66 REMARK 500 LYS B 110 -62.39 -10.30 REMARK 500 LYS B 141 -5.50 80.27 REMARK 500 ARG B 142 32.88 -88.11 REMARK 500 SER B 143 98.04 -63.48 REMARK 500 SER B 145 166.39 -45.42 REMARK 500 ASP B 202 74.34 -100.84 REMARK 500 ASP B 260 49.75 -81.06 REMARK 500 SER B 262 -175.07 -68.66 REMARK 500 HIS B 279 33.74 -95.01 REMARK 500 ASN B 285 39.84 -152.54 REMARK 500 ALA B 353 60.79 -157.48 REMARK 500 THR B 366 -61.47 -98.69 REMARK 500 ARG B 374 -137.11 -120.33 REMARK 500 ASP B 386 43.60 76.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2030 DISTANCE = 5.09 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 500 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HEM A 500 NB REMARK 620 2 HEM A 500 NC 88.9 REMARK 620 3 CYS A 186 SG 87.8 89.5 REMARK 620 4 HEM A 500 ND 179.0 90.6 93.0 REMARK 620 5 HEM A 500 NA 90.3 179.2 90.6 90.2 REMARK 620 6 E2Z A 800 N01 83.6 85.8 170.3 95.5 93.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM B 500 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HEM B 500 ND REMARK 620 2 E2Z B 800 N01 88.4 REMARK 620 3 HEM B 500 NB 178.3 90.0 REMARK 620 4 HEM B 500 NA 89.6 87.1 90.8 REMARK 620 5 HEM B 500 NC 90.9 92.1 88.7 179.1 REMARK 620 6 CYS B 186 SG 92.5 177.9 89.1 91.0 89.8 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 900 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 101 SG REMARK 620 2 CYS B 96 SG 108.5 REMARK 620 3 CYS A 101 SG 107.8 101.2 REMARK 620 4 CYS A 96 SG 105.2 125.1 108.0 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE E2Z A 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 860 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 880 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 900 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM B 500 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE H4B B 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE E2Z B 800 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 861 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL B 880 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4D2Y RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-(S,R)-2-(3-FLUOROBENZYL) REMARK 900 CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D2Z RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-(R,S)-2-(3-FLUOROBENZYL) REMARK 900 CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D30 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(PYRIDIN-3-YL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4D31 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(3-CYANOBENZYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D32 RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 3-(3-FLUOROPHENYL)-N-2-(2-( REMARK 900 5-METHYL-1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL)ETHYLPROPAN REMARK 900 -1-AMINE REMARK 900 RELATED ID: 4D33 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH (N1-(2-(1H-IMIDAZOL-1- REMARK 900 YL)PYRIMIDIN-4-YL)-N2-(3-FLUOROPHENETHYL)ETHANE-1,2 REMARK 900 -DIAMINE REMARK 900 RELATED ID: 4D35 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 REMARK 900 -YL)PYRIMIDIN-4-YL)ETHYL-3-(3-FLUOROPHENYL)PROPAN-1 REMARK 900 -AMINE REMARK 900 RELATED ID: 4D36 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 REMARK 900 -YL)PYRIMIDIN-4-YL)ETHYL-3-(3-CHLOROPHENYL)PROPAN-1 REMARK 900 -AMINE REMARK 900 RELATED ID: 4D37 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITHN-{[(1R,2R)-2-(3- REMARK 900 FLUOROPHENYL)CYCLOPROPYL]METHYL}-2-[2-(1H-IMIDAZOL-1- REMARK 900 YL)PYRIMIDIN-4-YL]ETHANAMINE REMARK 900 RELATED ID: 4D38 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1 REMARK 900 -YL)PYRIMIDIN-4-YL)ETHYL-(S,R)-2-(3-FLUOROBENZYL) REMARK 900 CYCLOPROPAN-1-AMINE REMARK 900 RELATED ID: 4D39 RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(3-CYANOBENZYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4D3A RELATED DB: PDB REMARK 900 STRUCTURE OF BOVINE ENDOTHELIAL NITRIC OXIDE SYNTHASE REMARK 900 HEME DOMAIN IN COMPLEX WITH 3-(3-FLUOROPHENYL)-N-2 REMARK 900 -(2-(5-METHYL-1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL) REMARK 900 ETHYLPROPAN-1-AMINE REMARK 900 RELATED ID: 4D3B RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N1-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N2-(3-FLUOROPHENETHYL)ETHANE-1,2- REMARK 900 DIAMINE REMARK 900 RELATED ID: 4V3U RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN NNOS R354A G357D MUTANT HEME DOMAIN REMARK 900 IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(PYRIDIN-3-YL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4V3V RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-(2-(1H-IMIDAZOL-1-YL)-4- REMARK 900 PYRIMIDYLMETHYL)-3-(3-FLUOROPHENYL)PROPAN-1-AMINE REMARK 900 RELATED ID: 4V3W RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(3-FLUOROPHENETHYL)ETHAN-1-AMINE REMARK 900 RELATED ID: 4V3X RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(3-FLUOROPHENYL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4V3Y RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH N-2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)ETHYL-3-(3-CHLOROPHENYL)PROPAN-1- REMARK 900 AMINE REMARK 900 RELATED ID: 4V3Z RELATED DB: PDB REMARK 900 STRUCTURE OF RAT NEURONAL NITRIC OXIDE SYNTHASE HEME REMARK 900 DOMAIN IN COMPLEX WITH 2-(2-(1H-IMIDAZOL-1-YL) REMARK 900 PYRIMIDIN-4-YL)-N-(2-(3-FLUOROPHENYL)CYCLOPROPYLMETHYL) REMARK 900 ETHAN-1-AMINE REMARK 999 REMARK 999 SEQUENCE REMARK 999 RESIDUE 100 IS FOUND AS AN ARG IN STRUCTURE BUT IS A CYS REMARK 999 IN DATABASE DBREF 4D34 A 40 482 UNP P29473 NOS3_BOVIN 40 482 DBREF 4D34 B 40 482 UNP P29473 NOS3_BOVIN 40 482 SEQADV 4D34 ARG A 100 UNP P29473 CYS 100 CONFLICT SEQADV 4D34 ARG B 100 UNP P29473 CYS 100 CONFLICT SEQRES 1 A 443 ARG ALA PRO ALA PRO ALA THR PRO HIS ALA PRO ASP HIS SEQRES 2 A 443 SER PRO ALA PRO ASN SER PRO THR LEU THR ARG PRO PRO SEQRES 3 A 443 GLU GLY PRO LYS PHE PRO ARG VAL LYS ASN TRP GLU LEU SEQRES 4 A 443 GLY SER ILE THR TYR ASP THR LEU CYS ALA GLN SER GLN SEQRES 5 A 443 GLN ASP GLY PRO CYS THR PRO ARG ARG CYS LEU GLY SER SEQRES 6 A 443 LEU VAL LEU PRO ARG LYS LEU GLN THR ARG PRO SER PRO SEQRES 7 A 443 GLY PRO PRO PRO ALA GLU GLN LEU LEU SER GLN ALA ARG SEQRES 8 A 443 ASP PHE ILE ASN GLN TYR TYR SER SER ILE LYS ARG SER SEQRES 9 A 443 GLY SER GLN ALA HIS GLU GLU ARG LEU GLN GLU VAL GLU SEQRES 10 A 443 ALA GLU VAL ALA SER THR GLY THR TYR HIS LEU ARG GLU SEQRES 11 A 443 SER GLU LEU VAL PHE GLY ALA LYS GLN ALA TRP ARG ASN SEQRES 12 A 443 ALA PRO ARG CYS VAL GLY ARG ILE GLN TRP GLY LYS LEU SEQRES 13 A 443 GLN VAL PHE ASP ALA ARG ASP CYS SER SER ALA GLN GLU SEQRES 14 A 443 MET PHE THR TYR ILE CYS ASN HIS ILE LYS TYR ALA THR SEQRES 15 A 443 ASN ARG GLY ASN LEU ARG SER ALA ILE THR VAL PHE PRO SEQRES 16 A 443 GLN ARG ALA PRO GLY ARG GLY ASP PHE ARG ILE TRP ASN SEQRES 17 A 443 SER GLN LEU VAL ARG TYR ALA GLY TYR ARG GLN GLN ASP SEQRES 18 A 443 GLY SER VAL ARG GLY ASP PRO ALA ASN VAL GLU ILE THR SEQRES 19 A 443 GLU LEU CYS ILE GLN HIS GLY TRP THR PRO GLY ASN GLY SEQRES 20 A 443 ARG PHE ASP VAL LEU PRO LEU LEU LEU GLN ALA PRO ASP SEQRES 21 A 443 GLU ALA PRO GLU LEU PHE VAL LEU PRO PRO GLU LEU VAL SEQRES 22 A 443 LEU GLU VAL PRO LEU GLU HIS PRO THR LEU GLU TRP PHE SEQRES 23 A 443 ALA ALA LEU GLY LEU ARG TRP TYR ALA LEU PRO ALA VAL SEQRES 24 A 443 SER ASN MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER SEQRES 25 A 443 ALA ALA PRO PHE SER GLY TRP TYR MET SER THR GLU ILE SEQRES 26 A 443 GLY THR ARG ASN LEU CYS ASP PRO HIS ARG TYR ASN ILE SEQRES 27 A 443 LEU GLU ASP VAL ALA VAL CAS MET ASP LEU ASP THR ARG SEQRES 28 A 443 THR THR SER SER LEU TRP LYS ASP LYS ALA ALA VAL GLU SEQRES 29 A 443 ILE ASN LEU ALA VAL LEU HIS SER PHE GLN LEU ALA LYS SEQRES 30 A 443 VAL THR ILE VAL ASP HIS HIS ALA ALA THR VAL SER PHE SEQRES 31 A 443 MET LYS HIS LEU ASP ASN GLU GLN LYS ALA ARG GLY GLY SEQRES 32 A 443 CYS PRO ALA ASP TRP ALA TRP ILE VAL PRO PRO ILE SER SEQRES 33 A 443 GLY SER LEU THR PRO VAL PHE HIS GLN GLU MET VAL ASN SEQRES 34 A 443 TYR ILE LEU SER PRO ALA PHE ARG TYR GLN PRO ASP PRO SEQRES 35 A 443 TRP SEQRES 1 B 443 ARG ALA PRO ALA PRO ALA THR PRO HIS ALA PRO ASP HIS SEQRES 2 B 443 SER PRO ALA PRO ASN SER PRO THR LEU THR ARG PRO PRO SEQRES 3 B 443 GLU GLY PRO LYS PHE PRO ARG VAL LYS ASN TRP GLU LEU SEQRES 4 B 443 GLY SER ILE THR TYR ASP THR LEU CYS ALA GLN SER GLN SEQRES 5 B 443 GLN ASP GLY PRO CYS THR PRO ARG ARG CYS LEU GLY SER SEQRES 6 B 443 LEU VAL LEU PRO ARG LYS LEU GLN THR ARG PRO SER PRO SEQRES 7 B 443 GLY PRO PRO PRO ALA GLU GLN LEU LEU SER GLN ALA ARG SEQRES 8 B 443 ASP PHE ILE ASN GLN TYR TYR SER SER ILE LYS ARG SER SEQRES 9 B 443 GLY SER GLN ALA HIS GLU GLU ARG LEU GLN GLU VAL GLU SEQRES 10 B 443 ALA GLU VAL ALA SER THR GLY THR TYR HIS LEU ARG GLU SEQRES 11 B 443 SER GLU LEU VAL PHE GLY ALA LYS GLN ALA TRP ARG ASN SEQRES 12 B 443 ALA PRO ARG CYS VAL GLY ARG ILE GLN TRP GLY LYS LEU SEQRES 13 B 443 GLN VAL PHE ASP ALA ARG ASP CYS SER SER ALA GLN GLU SEQRES 14 B 443 MET PHE THR TYR ILE CYS ASN HIS ILE LYS TYR ALA THR SEQRES 15 B 443 ASN ARG GLY ASN LEU ARG SER ALA ILE THR VAL PHE PRO SEQRES 16 B 443 GLN ARG ALA PRO GLY ARG GLY ASP PHE ARG ILE TRP ASN SEQRES 17 B 443 SER GLN LEU VAL ARG TYR ALA GLY TYR ARG GLN GLN ASP SEQRES 18 B 443 GLY SER VAL ARG GLY ASP PRO ALA ASN VAL GLU ILE THR SEQRES 19 B 443 GLU LEU CYS ILE GLN HIS GLY TRP THR PRO GLY ASN GLY SEQRES 20 B 443 ARG PHE ASP VAL LEU PRO LEU LEU LEU GLN ALA PRO ASP SEQRES 21 B 443 GLU ALA PRO GLU LEU PHE VAL LEU PRO PRO GLU LEU VAL SEQRES 22 B 443 LEU GLU VAL PRO LEU GLU HIS PRO THR LEU GLU TRP PHE SEQRES 23 B 443 ALA ALA LEU GLY LEU ARG TRP TYR ALA LEU PRO ALA VAL SEQRES 24 B 443 SER ASN MET LEU LEU GLU ILE GLY GLY LEU GLU PHE SER SEQRES 25 B 443 ALA ALA PRO PHE SER GLY TRP TYR MET SER THR GLU ILE SEQRES 26 B 443 GLY THR ARG ASN LEU CYS ASP PRO HIS ARG TYR ASN ILE SEQRES 27 B 443 LEU GLU ASP VAL ALA VAL CAS MET ASP LEU ASP THR ARG SEQRES 28 B 443 THR THR SER SER LEU TRP LYS ASP LYS ALA ALA VAL GLU SEQRES 29 B 443 ILE ASN LEU ALA VAL LEU HIS SER PHE GLN LEU ALA LYS SEQRES 30 B 443 VAL THR ILE VAL ASP HIS HIS ALA ALA THR VAL SER PHE SEQRES 31 B 443 MET LYS HIS LEU ASP ASN GLU GLN LYS ALA ARG GLY GLY SEQRES 32 B 443 CYS PRO ALA ASP TRP ALA TRP ILE VAL PRO PRO ILE SER SEQRES 33 B 443 GLY SER LEU THR PRO VAL PHE HIS GLN GLU MET VAL ASN SEQRES 34 B 443 TYR ILE LEU SER PRO ALA PHE ARG TYR GLN PRO ASP PRO SEQRES 35 B 443 TRP MODRES 4D34 CAS A 384 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 4D34 CAS B 384 CYS S-(DIMETHYLARSENIC)CYSTEINE HET CAS A 384 9 HET HEM A 500 43 HET H4B A 600 17 HET E2Z A 800 23 HET ACT A 860 4 HET GOL A 880 6 HET ZN A 900 1 HET CAS B 384 9 HET HEM B 500 43 HET H4B B 600 17 HET E2Z B 800 23 HET ACT B 861 4 HET GOL B 880 6 HETNAM H4B 5,6,7,8-TETRAHYDROBIOPTERIN HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM ZN ZINC ION HETNAM GOL GLYCEROL HETNAM ACT ACETATE ION HETNAM E2Z 2-(3-FLUOROPHENYL)-N-{2-[2-(1H-IMIDAZOL-1-YL) HETNAM 2 E2Z PYRIMIDIN-4-YL]ETHYL}ETHANAMINE HETNAM CAS S-(DIMETHYLARSENIC)CYSTEINE HETSYN HEM HEME HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL HETSYN E2Z 2-(2-(1H-IMIDAZOL-1-YL)PYRIMIDIN-4-YL)-N-(3- HETSYN 2 E2Z FLUOROPHENETHYL)ETHAN-1-AMINE FORMUL 2 H4B 2(C9 H15 N5 O3) FORMUL 3 HEM 2(C34 H32 FE N4 O4) FORMUL 4 ZN ZN 2+ FORMUL 5 GOL 2(C3 H8 O3) FORMUL 6 ACT 2(C2 H3 O2 1-) FORMUL 7 E2Z 2(C17 H18 F N5) FORMUL 8 CAS 2(C5 H12 AS N O2 S) FORMUL 9 HOH *173(H2 O) HELIX 1 1 THR A 85 SER A 90 5 6 HELIX 2 2 ALA A 122 ILE A 140 1 19 HELIX 3 3 SER A 145 GLY A 163 1 19 HELIX 4 4 ARG A 168 ALA A 183 1 16 HELIX 5 5 GLY A 188 TRP A 192 5 5 HELIX 6 6 SER A 205 ASN A 222 1 18 HELIX 7 7 ARG A 223 ASN A 225 5 3 HELIX 8 8 ASN A 269 HIS A 279 1 11 HELIX 9 9 PRO A 308 VAL A 312 5 5 HELIX 10 10 LEU A 322 GLY A 329 5 8 HELIX 11 11 MET A 360 THR A 366 1 7 HELIX 12 12 THR A 366 ASP A 371 1 6 HELIX 13 13 ILE A 377 MET A 385 1 9 HELIX 14 14 THR A 391 SER A 394 5 4 HELIX 15 15 LEU A 395 ALA A 415 1 21 HELIX 16 16 ASP A 421 GLY A 441 1 21 HELIX 17 17 ASP A 446 VAL A 451 1 6 HELIX 18 18 SER A 455 THR A 459 5 5 HELIX 19 19 THR A 459 HIS A 463 5 5 HELIX 20 20 THR B 85 SER B 90 5 6 HELIX 21 21 PRO B 121 ILE B 140 1 20 HELIX 22 22 SER B 145 GLY B 163 1 19 HELIX 23 23 ARG B 168 ASN B 182 1 15 HELIX 24 24 GLY B 188 TRP B 192 5 5 HELIX 25 25 SER B 205 ASN B 222 1 18 HELIX 26 26 ARG B 223 ASN B 225 5 3 HELIX 27 27 ASN B 269 HIS B 279 1 11 HELIX 28 28 PRO B 308 VAL B 312 5 5 HELIX 29 29 TRP B 324 GLY B 329 5 6 HELIX 30 30 MET B 360 THR B 366 1 7 HELIX 31 31 THR B 366 ASP B 371 1 6 HELIX 32 32 ILE B 377 ASP B 386 1 10 HELIX 33 33 THR B 391 SER B 394 5 4 HELIX 34 34 LEU B 395 ALA B 415 1 21 HELIX 35 35 ASP B 421 GLY B 441 1 21 HELIX 36 36 ASP B 446 VAL B 451 1 6 HELIX 37 37 SER B 455 THR B 459 5 5 HELIX 38 38 THR B 459 HIS B 463 5 5 SHEET 1 AA 2 ARG A 72 LYS A 74 0 SHEET 2 AA 2 ILE A 81 TYR A 83 -1 O THR A 82 N VAL A 73 SHEET 1 AB 4 GLN A 196 ASP A 199 0 SHEET 2 AB 4 ALA A 229 VAL A 232 1 O ILE A 230 N PHE A 198 SHEET 3 AB 4 PHE A 355 SER A 356 -1 O SER A 356 N ALA A 229 SHEET 4 AB 4 ALA A 337 VAL A 338 -1 O VAL A 338 N PHE A 355 SHEET 1 AC 3 ARG A 244 ILE A 245 0 SHEET 2 AC 3 LEU A 293 GLN A 296 -1 O GLN A 296 N ARG A 244 SHEET 3 AC 3 GLU A 303 PHE A 305 -1 O GLU A 303 N LEU A 295 SHEET 1 AD 2 GLY A 255 ARG A 257 0 SHEET 2 AD 2 VAL A 263 GLY A 265 -1 O ARG A 264 N TYR A 256 SHEET 1 AE 2 GLU A 314 PRO A 316 0 SHEET 2 AE 2 ARG A 331 TYR A 333 -1 O TRP A 332 N VAL A 315 SHEET 1 AF 3 LEU A 348 PHE A 350 0 SHEET 2 AF 3 LEU A 342 ILE A 345 -1 O LEU A 343 N PHE A 350 SHEET 3 AF 3 ALA A 474 ARG A 476 -1 O ALA A 474 N GLU A 344 SHEET 1 BA 2 ARG B 72 LYS B 74 0 SHEET 2 BA 2 ILE B 81 TYR B 83 -1 O THR B 82 N VAL B 73 SHEET 1 BB 4 GLN B 196 ASP B 199 0 SHEET 2 BB 4 ALA B 229 VAL B 232 1 O ILE B 230 N PHE B 198 SHEET 3 BB 4 PHE B 355 SER B 356 -1 O SER B 356 N ALA B 229 SHEET 4 BB 4 ALA B 337 VAL B 338 -1 O VAL B 338 N PHE B 355 SHEET 1 BC 3 ARG B 244 ILE B 245 0 SHEET 2 BC 3 LEU B 293 GLN B 296 -1 O GLN B 296 N ARG B 244 SHEET 3 BC 3 GLU B 303 PHE B 305 -1 O GLU B 303 N LEU B 295 SHEET 1 BD 2 GLY B 255 ARG B 257 0 SHEET 2 BD 2 VAL B 263 GLY B 265 -1 O ARG B 264 N TYR B 256 SHEET 1 BE 2 GLU B 314 PRO B 316 0 SHEET 2 BE 2 ARG B 331 TYR B 333 -1 O TRP B 332 N VAL B 315 SHEET 1 BF 3 LEU B 348 PHE B 350 0 SHEET 2 BF 3 LEU B 342 ILE B 345 -1 O LEU B 343 N PHE B 350 SHEET 3 BF 3 ALA B 474 ARG B 476 -1 O ALA B 474 N GLU B 344 LINK SG CYS A 186 FE HEM A 500 1555 1555 2.31 LINK C VAL A 383 N CAS A 384 1555 1555 1.34 LINK C CAS A 384 N MET A 385 1555 1555 1.32 LINK FE HEM A 500 N01 E2Z A 800 1555 1555 2.06 LINK ZN ZN A 900 SG CYS B 101 1555 1555 2.18 LINK ZN ZN A 900 SG CYS B 96 1555 1555 2.47 LINK ZN ZN A 900 SG CYS A 101 1555 1555 2.52 LINK ZN ZN A 900 SG CYS A 96 1555 1555 2.36 LINK SG CYS B 186 FE HEM B 500 1555 1555 2.34 LINK C VAL B 383 N CAS B 384 1555 1555 1.33 LINK C CAS B 384 N MET B 385 1555 1555 1.34 LINK FE HEM B 500 N01 E2Z B 800 1555 1555 2.01 CISPEP 1 SER A 472 PRO A 473 0 0.28 CISPEP 2 SER B 472 PRO B 473 0 5.66 SITE 1 AC1 15 TRP A 180 ARG A 185 CYS A 186 VAL A 187 SITE 2 AC1 15 SER A 228 PHE A 355 SER A 356 TRP A 358 SITE 3 AC1 15 GLU A 363 TRP A 449 PHE A 475 TYR A 477 SITE 4 AC1 15 H4B A 600 E2Z A 800 HOH A2093 SITE 1 AC2 11 SER A 104 ARG A 367 ALA A 448 TRP A 449 SITE 2 AC2 11 HEM A 500 GOL A 880 HOH A2062 HOH A2066 SITE 3 AC2 11 HOH A2085 TRP B 447 PHE B 462 SITE 1 AC3 7 GLN A 249 PRO A 336 VAL A 338 GLU A 363 SITE 2 AC3 7 HEM A 500 GOL A 880 TRP B 76 SITE 1 AC4 4 GLY A 188 TRP A 358 VAL A 420 SER A 428 SITE 1 AC5 8 VAL A 106 ARG A 367 HIS A 373 TRP A 449 SITE 2 AC5 8 H4B A 600 E2Z A 800 HOH A2066 TRP B 76 SITE 1 AC6 4 CYS A 96 CYS A 101 CYS B 96 CYS B 101 SITE 1 AC7 14 TRP B 180 ARG B 185 CYS B 186 VAL B 187 SITE 2 AC7 14 SER B 228 PHE B 355 SER B 356 TRP B 358 SITE 3 AC7 14 GLU B 363 TRP B 449 TYR B 477 H4B B 600 SITE 4 AC7 14 E2Z B 800 HOH B2080 SITE 1 AC8 10 TRP A 447 PHE A 462 HOH A2089 SER B 104 SITE 2 AC8 10 ARG B 367 ALA B 448 TRP B 449 HEM B 500 SITE 3 AC8 10 GOL B 880 HOH B2075 SITE 1 AC9 10 TRP A 76 LEU B 107 GLN B 249 PRO B 336 SITE 2 AC9 10 VAL B 338 GLU B 363 TYR B 477 HEM B 500 SITE 3 AC9 10 ACT B 861 GOL B 880 SITE 1 BC1 6 GLN B 249 ARG B 252 TYR B 359 GLU B 363 SITE 2 BC1 6 ASN B 368 E2Z B 800 SITE 1 BC2 8 TRP A 76 HOH A2089 VAL B 106 ARG B 367 SITE 2 BC2 8 HIS B 373 TRP B 449 H4B B 600 E2Z B 800 CRYST1 58.159 106.632 156.638 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017194 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009378 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006384 0.00000